IP Library Assignment 052397/0854
Patent Assignment
Reel/Frame 052397/0854

Change of Name

Recorded: 2020-04-14 Pages: 4
Assignor
LION BIOTECHNOLOGIES, INC.
Executed: 2017-06-27
Assignee
IOVANCE BIOTHERAPEUTICS, INC.
999 SKYWAY ROAD, SUITE 150, SAN CARLOS, CALIFORNIA, 94070
Covered Properties (6)
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,361 →
Publication: US 2020/0276241
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,386 →
Publication: US 2020/0306306
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,426 →
Publication: US 2020/0306307
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,442 →
Publication: US 2020/0246384
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,454 →
Publication: US 2020/0276242
Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy
Application: 16/848,474 →
Publication: US 2020/0281978
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 14, 2020
From: BENDER, JAMES; WARDELL, SETH; LOTZE, MICHAEL T.
To: LION BIOTECHNOLOGIES, INC.
Reel/Frame 052394/0900 →